regeneron dna - Search News

Order byBest matchMost fresh

Regeneron Pharmaceuticals to buy 23andMe and its data

Top News

Overview

Impacts

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

But, more concerning than the success or failure of a particular company, was this question: What would happen to 23andMe's vast trove of highly personal customer data? We aren't just talking about usernames and birthdays.

· 16h · on MSN

· 1h · on MSN

Pharmaceutical company Regeneron buying 23andMe for $256 million

· 16h · on MSN

23andMe To Be Sold in Bankruptcy: What It Means for Your DNA Data

Regeneron agrees to buy bankrupt 23andMe

Regeneron Pharmaceuticals said on Monday it will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of customers' DNA da...

· 20h

· 23h

Struggling DNA testing firm 23andMe to be bought for $256m

· 21h

23andMe (and Your Genetic Data) Sold to Regeneron in Bankruptcy Auction

Genetic data will be safeguarded with 23andMe sale, drugmaker vows

Regeneron Pharmaceuticals said Monday it will acquire 23andMe’s DNA testing business and most of its assets out of bankruptcy and pledged to continue offering the popular consumer service and adopt it...

· 17h

· 23h

23andMe sells its most valuable asset to biotech company Regeneron, which promises to keep your DNA private

· 1d

Biotechnology company Regeneron buying 23andMe for $256 million

Lohud.com, Westchester County on MSN19h

Regeneron to acquire 23andMe DNA testing firm. How that could impact your genetic data

Regeneron announced a plan to acquire genetic testing firm 23andMe through bankruptcy court, including access to personal genetic data. What to know

Daily Voice Somerset County, NJ on MSN1h

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services with no changes.

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

Stocktwits on MSN1d

Regeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D Efforts

Drugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology company 23andMe Holding Co. for $256 million. Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS),